Pharmacoepidemiology of Immune Thrombocytopenia: Protocols of FAITH and CARMEN Studies
Therapie, 69 5 (2014) 437-448
Published online: 2014-10-07
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Association between megakaryocyte abnormalities on bone marrow smear and response to thrombopoietin receptor agonists in adult patients with primary immune thrombocytopenia
Ondine Walter, Agnès Ribes, Johanne Germain, Jean-Baptiste Rieu, Thibaut Comont, Albertine Plat, Brigitte Rivière, Laureline Deluche, Lucrecia Delarue, Isabelle LeGoff, Monique Greze, Béatrice Dubourdieu, Odile Rauzy, Veronique Mansat-De Mas and Guillaume MoulisPlatelets 33 (8) 1153 (2022)
https://doi.org/10.1080/09537104.2022.2053089
Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia
Vincent Jachiet, Guillaume Moulis, Jérome Hadjadj, et al.Haematologica 106 (5) 1414 (2021)
https://doi.org/10.3324/haematol.2020.272559
Vaccination during the First Diagnosis of Multiple Myeloma: A Cohort Study of the French National Health Insurance Database
Guilhem Tournaire, Cécile Conte, Aurore Perrot, Maryse Lapeyre-Mester and Fabien DespasVaccines 8 (4) 722 (2020)
https://doi.org/10.3390/vaccines8040722
The challenges of pharmacoepidemiology of orphan drugs in rare diseases
Maryse Lapeyre-MestreTherapies 75 (2) 215 (2020)
https://doi.org/10.1016/j.therap.2020.02.013
Positivity rate of systematic bone marrow smear in patients over 60 years old with newly diagnosed immune thrombocytopenia
Guillaume Moulis, Daniel Adoue, Odile Beyne-Rauzy, Johanne Germain and Thibault ComontBlood Advances 4 (10) 2136 (2020)
https://doi.org/10.1182/bloodadvances.2020001654
The value of a health insurance database to conduct pharmacoepidemiological studies in oncology
Cécile Conte, Charlotte Vaysse, Pauline Bosco, Pernelle Noize, Annie Fourrier-Reglat, Fabien Despas and Maryse Lapeyre-MestreTherapies 74 (2) 279 (2019)
https://doi.org/10.1016/j.therap.2018.09.076
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
M.-L. Piel-Julian, M. Mahévas, J. Germain, et al.Journal of Thrombosis and Haemostasis 16 (9) 1830 (2018)
https://doi.org/10.1111/jth.14227
Pretreatment with standard‐dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP)
Anaïs Essilini, Thibault Comont, Johanne Germain, Natacha Brun, Claire Dingremont, Brice Castel, Sophie Arista, Serge Madaule, Laurent Sailler, Maryse Lapeyre‐Mestre, Odile Beyne‐Rauzy, Bertrand Godeau, Daniel Adoue and Guillaume MoulisEuropean Journal of Haematology 100 (5) 412 (2018)
https://doi.org/10.1111/ejh.13032
Épidémiologie et pharmacoépidémiologie du purpura thrombopénique immunologique
G. Moulis, M. Lapeyre-Mestre, D. Adoue and L. SaillerLa Revue de Médecine Interne 38 (7) 444 (2017)
https://doi.org/10.1016/j.revmed.2016.12.016
Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect
G. Moulis, M. Lapeyre-Mestre, A. Palmaro and L. SaillerJournal of Thrombosis and Haemostasis 15 (4) 785 (2017)
https://doi.org/10.1111/jth.13622
Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort
Guillaume Moulis, Johanne Germain, Thibault Comont, Natacha Brun, Claire Dingremont, Brice Castel, Sophie Arista, Laurent Sailler, Maryse Lapeyre‐Mestre, Odile Beyne‐Rauzy, Bertrand Godeau and Daniel AdoueAmerican Journal of Hematology 92 (6) 493 (2017)
https://doi.org/10.1002/ajh.24702
Validation of an algorithm identifying incident primary immune thrombocytopenia in the French national health insurance database
Salim Mezaache, Helene Derumeaux, Pierre Ferraro, Pascal Capdepon, Jean‐Christophe Steinbach, Xavier Abballe, Deborah Palas, Nabil Saichi, Karine Desboeuf, Maryse Lapeyre‐Mestre, Laurent Sailler and Guillaume MoulisEuropean Journal of Haematology 99 (4) 344 (2017)
https://doi.org/10.1111/ejh.12926
Validation of immune thrombocytopenia diagnosis code in the French hospital electronic database
Guillaume Moulis, Johanne Germain, Daniel Adoue, et al.European Journal of Internal Medicine 32 e21 (2016)
https://doi.org/10.1016/j.ejim.2016.02.021
Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study
Guillaume Moulis, Maryse Lapeyre-Mestre, Jean-Louis Montastruc and Laurent SaillerAutoimmunity Reviews 14 (2) 168 (2015)
https://doi.org/10.1016/j.autrev.2014.10.017
Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study
Guillaume Moulis, Aurore Palmaro, Laurent Sailler, Maryse Lapeyre-Mestre and Joerg LatusPLOS ONE 10 (11) e0142217 (2015)
https://doi.org/10.1371/journal.pone.0142217
Prescription et rentabilité diagnostique du bilan paraclinique au diagnostic de thrombopénie immunologique. Résultats du registre CARMEN
G. Moulis, T. Comont, N. Brun, C. Dingremont, B. Castel, S. Arista, S. Madaule, P. Montané De La Roque, L. Prudhomme, M. Lapeyre-Mestre, O. Beyne-rauzy and D. AdoueLa Revue de Médecine Interne 36 A51 (2015)
https://doi.org/10.1016/j.revmed.2015.03.285
Fonction de risque d’infection grave des corticoïdes dans la thrombopénie immunologique primaire persistante ou chronique. Étude cas-témoins nichée dans la cohorte FAITH
G. Moulis, L. Sailler and M. Lapeyre-MestreLa Revue de Médecine Interne 36 A53 (2015)
https://doi.org/10.1016/j.revmed.2015.03.287
French health insurance databases: What interest for medical research?
G. Moulis, M. Lapeyre-Mestre, A. Palmaro, G. Pugnet, J.-L. Montastruc and L. SaillerLa Revue de Médecine Interne 36 (6) 411 (2015)
https://doi.org/10.1016/j.revmed.2014.11.009
Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population‐based study in France
Guillaume Moulis, Maryse Lapeyre‐Mestre, Matthieu Mahévas, Jean‐Louis Montastruc and Laurent SaillerAmerican Journal of Hematology 90 (4) 301 (2015)
https://doi.org/10.1002/ajh.23930
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review: comment
G. Moulis, L. Sailler and M. Lapeyre‐MestreJournal of Thrombosis and Haemostasis 13 (8) 1521 (2015)
https://doi.org/10.1111/jth.12984